D. F. David

1.0k total citations
25 papers, 672 citations indexed

About

D. F. David is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, D. F. David has authored 25 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in D. F. David's work include Hematopoietic Stem Cell Transplantation (5 papers), T-cell and B-cell Immunology (5 papers) and Multiple Sclerosis Research Studies (4 papers). D. F. David is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), T-cell and B-cell Immunology (5 papers) and Multiple Sclerosis Research Studies (4 papers). D. F. David collaborates with scholars based in Australia, United Kingdom and United States. D. F. David's co-authors include Helen Tao, John J. Moore, Renuka Rao, Jennifer Massey, Ian Sutton, Vivek Jayaswal, Adrian Cuda Banda Meedeniya, Alan Mackay‐Sim, Adam Bryant and Catalina A. Palma and has published in prestigious journals such as PLoS ONE, Cancer and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

D. F. David

25 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. F. David Australia 14 264 173 158 154 115 25 672
Robert Bayer United States 17 131 0.5× 130 0.8× 215 1.4× 144 0.9× 262 2.3× 23 754
Hong-Min Yan China 15 354 1.3× 267 1.5× 393 2.5× 53 0.3× 85 0.7× 43 808
Cicely A. Williams United States 8 263 1.0× 49 0.3× 174 1.1× 64 0.4× 46 0.4× 9 668
Ana Paiva Portugal 14 230 0.9× 114 0.7× 55 0.3× 33 0.2× 129 1.1× 31 622
Serena De Vita United States 13 283 1.1× 83 0.5× 157 1.0× 43 0.3× 118 1.0× 29 621
Alessandro Pastore Germany 16 384 1.5× 179 1.0× 259 1.6× 195 1.3× 182 1.6× 33 885
Amélia G. Araújo Brazil 14 232 0.9× 199 1.2× 102 0.6× 46 0.3× 91 0.8× 29 571
Xiaoqiang Han United States 14 213 0.8× 67 0.4× 118 0.7× 422 2.7× 132 1.1× 24 950
Sara Nava Italy 18 282 1.1× 216 1.2× 76 0.5× 31 0.2× 342 3.0× 29 894
Shi Hong Lu China 10 283 1.1× 313 1.8× 36 0.2× 54 0.4× 54 0.5× 13 654

Countries citing papers authored by D. F. David

Since Specialization
Citations

This map shows the geographic impact of D. F. David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. F. David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. F. David more than expected).

Fields of papers citing papers by D. F. David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. F. David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. F. David. The network helps show where D. F. David may publish in the future.

Co-authorship network of co-authors of D. F. David

This figure shows the co-authorship network connecting the top 25 collaborators of D. F. David. A scholar is included among the top collaborators of D. F. David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. F. David. D. F. David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
David, D. F., et al.. (2022). Potential benefits of a virtual, home-based combined exercise and mindfulness training program for HSC transplant survivors: a single-arm pilot study. BMC Sports Science Medicine and Rehabilitation. 14(1). 167–167. 4 indexed citations
2.
Visweswaran, Malini, Jennifer Massey, Barbara Withers, et al.. (2022). Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation. Frontiers in Immunology. 12. 782935–782935. 13 indexed citations
3.
Visweswaran, Malini, Jennifer Massey, John Zaunders, et al.. (2022). Sustained immunotolerance in multiple sclerosis after stem cell transplant. Annals of Clinical and Translational Neurology. 9(2). 206–220. 21 indexed citations
4.
5.
Visweswaran, Malini, et al.. (2019). Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplantation. 55(5). 857–866. 9 indexed citations
6.
Moore, John J., Jennifer Massey, John Zaunders, et al.. (2018). Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 90(5). 514–521. 70 indexed citations
7.
Massey, Jennifer, Ian Sutton, D. F. David, & John J. Moore. (2018). Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant. Frontiers in Immunology. 9. 410–410. 60 indexed citations
8.
Carlin, Stephen M., et al.. (2015). Pro-survival role of protein kinase C epsilon in Philadelphia chromosome positive acute leukemia. Leukemia & lymphoma. 57(2). 411–418. 5 indexed citations
9.
Palma, Catalina A., et al.. (2014). MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia. Molecular Cancer. 13(1). 79–79. 92 indexed citations
10.
Nivison‐Smith, Ian, Judy M. Simpson, Anthony J. Dodds, et al.. (2013). A population-based analysis of the effect of autologous hematopoietic cell transplant in the treatment of multiple myeloma. Leukemia & lymphoma. 54(8). 1671–1676. 9 indexed citations
11.
Nivison‐Smith, Ian, Anthony J. Dodds, Peter Ganly, et al.. (2011). Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998–2006: factors associated with improved survival outcome. Leukemia & lymphoma. 52(9). 1727–1735. 7 indexed citations
12.
Tao, Helen, et al.. (2011). Transplantation of Neuronal-Primed Human Bone Marrow Mesenchymal Stem Cells in Hemiparkinsonian Rodents. PLoS ONE. 6(5). e19025–e19025. 69 indexed citations
13.
Shen, Bojiang, Ai‐Qun Wei, Lisa A. Williams, et al.. (2009). BMP-13 Emerges as a Potential Inhibitor of Bone Formation. International Journal of Biological Sciences. 5(2). 192–200. 64 indexed citations
14.
Bai, Lijun, Yi‐Mo Deng, Anthony J. Dodds, et al.. (2006). A SYBR green‐based real‐time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients. European Journal Of Haematology. 77(5). 425–431. 18 indexed citations
15.
Tao, Helen, Renuka Rao, & D. F. David. (2005). Cytokine‐induced stable neuronal differentiation of human bone marrow mesenchymal stem cells in a serum/feeder cell‐free condition. Development Growth & Differentiation. 47(6). 423–433. 72 indexed citations
16.
Yin, Jianlin, et al.. (1995). Interferon response in chronic myeloid leukaemia correlates with ABL/BCR expression: a preliminary study. British Journal of Haematology. 89(3). 539–545. 15 indexed citations
17.
Woisard, Anne, et al.. (1994). TARGETED PHOTOCHEMICAL MODIFICATION OF HIV‐DERIVED OLIGORIBONUCLEOTIDES BY ANTISENSE OLIGODEOXYNUCLEOTIDES LINKED TO PORPHYRINS. Photochemistry and Photobiology. 60(4). 316–322. 23 indexed citations
18.
Yin, Jian, et al.. (1994). A Ph+Acute Myeloid Leukaemia Expressing Both CML-Type and ALL-Type BCR/ABL mRNA Transcripts. Leukemia & lymphoma. 14(3-4). 341–346. 5 indexed citations
19.
Ho, Anthony D., Bernd Dörken, D. F. David, et al.. (1986). Purine degradative enzymes and immunological phenotypes in chronic B‐lymphocytic leukaemia: indications that leukaemic immunocytoma is a separate entity. British Journal of Haematology. 62(3). 545–555. 8 indexed citations
20.
David, D. F., et al.. (1980). Cytotoxic-induced fulminant hyperpyrexia. Cancer. 45(9). 2249–2251. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Bayer Breakdown of academic impact, for papers by Hong-Min Yan Breakdown of academic impact, for papers by Cicely A. Williams Breakdown of academic impact, for papers by Ana Paiva Breakdown of academic impact, for papers by Serena De Vita Breakdown of academic impact, for papers by Alessandro Pastore Breakdown of academic impact, for papers by Amélia G. Araújo Breakdown of academic impact, for papers by Xiaoqiang Han Breakdown of academic impact, for papers by Sara Nava Breakdown of academic impact, for papers by Shi Hong Lu
Rankless by CCL
2026